Stanford University: Lung Neoplasms trials
The registry lists 28 Lung Neoplasms studies with Stanford University as lead sponsor. 6 are open to participants now and 6 have results posted.
Phase 1 7Phase 2 7No phase 17(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Adjuvant ctDNA-Adapted Treatment With Zipalertinib in Early-Stage Atypical EGFR-Mutant NSCLCNot yet recruitingNCT07802834Phase 2
- Personalized Accelerated ChEmoRadiation (PACER) for Lung CancerRecruitingNCT06080061Not applicable
- Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With CancerRecruitingNCT05297734Not applicable
- Panitumumab-IRDye800 in Detecting Cancer in Participants With Lung Cancer During SurgeryRecruitingNCT03582124Phase 1/2
- Molecular Analysis of Thoracic MalignanciesEnrolling by invitationNCT01385722
- Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung CancersRecruitingNCT00568490
- Regorafenib and Methotrexate in Treating Participants With Recurrent or Metastatic KRAS Mutated Non-Small Cell Lung CancerCompletedNCT03520842Phase 2Results posted
- Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With CancerCompletedNCT03154190Not applicableResults posted
- Engagement of Patients With Advanced CancerCompletedNCT02966509Not applicableResults posted
- Individualized Lung Tumor Stereotactic Ablative Radiotherapy (iSABR)CompletedNCT01463423Not applicableResults posted
- Phase II Bevacizumab, Gemcitabine and Carboplatin in Newly Diagnosed Non-Small Cell Lung CancerCompletedNCT00323869Phase 2Results posted
- Phase II Docetaxel / Carboplatin / XRT + Surgical Resection in Stage III NSCLCTerminatedNCT00238615Phase 2Results posted
- Ensuring Precision-Medicine Delivery for Veterans With Lung CancerCompletedNCT05795959Not applicable
- Study to Evaluate Percussive Ventilation Breathhold to Improve Lung Stereotactic Ablative RadiotherapyCompletedNCT05283564Not applicable
- Biodistribution & Pharmacokinetic of Position Emission Tomography (PET) Radiopharmaceutical 18F C SNAT4SuspendedNCT04017819Phase 1
- CT Perfusion Imaging in Predicting Treatment Response in Patients With Non-small Cell Lung Cancer or Lung Metastases Treated With Stereotactic Ablative Radiation TherapyCompletedNCT02693080Phase 1
- Cognitive Behavioral Therapy in Treating Anxiety in Patients With Stage IV Non-Small Cell Lung Cancer and Their CaregiversCompletedNCT01729689Not applicable
- Talactoferrin in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer or Squamous Cell Head and Neck CancerTerminatedNCT01528137Phase 1
- Pulmonary Interstitial Lymphography in Early Stage Lung CancerTerminatedNCT01188486Not applicable
- Breath Analysis for Evaluation of Radiation Exposure in Lung Cancer Patients Treated With RadiationCompletedNCT01182155
- Clinical and Pathologic Studies of Patients Undergoing Treatment With EGFR InhibitorsTerminatedNCT01137162
- Feasibility of Using Real-time Cine-MRI for Treating Moving & Deforming TumorsTerminatedNCT01071434
- Phase I Vorinostat Concurrent With Stereotactic Radiosurgery (SRS) in Brain Metastases From Non-Small Cell Lung CancerCompletedNCT00946673Phase 1
- Microarray Analysis of Gene Expression and Identification of Progenitor Cells in Lung CarcinomaTerminatedNCT00568906
- Identification of Circulating Tumor Cells in the Peripheral Blood of Lung Cancer PatientsCompletedNCT00568282
- A Phase I/II Study of Bexarotene in Combination With ZD1839 (IRESSA®) in the Treatment of Non-Small Cell Lung CancerCompletedNCT00238628Phase 1/2
- Evaluation of Cyberknife Precision Radiation Delivery System for Unresectable Malignant Lung CancerCompletedNCT00238602Phase 1/2
- Identification of Serum Markers For Tumor Hypoxia in Non-Small Cell Lung CancersCompletedNCT00185913